58 results
8-K
EX-3.2
PNT
POINT Biopharma Global Inc.
27 Dec 23
Termination of a Material Definitive Agreement
8:54am
of any special meeting shall state in general terms the purpose or purposes for which the meeting is to be held.
Section 4. Stockholder Lists … of directors then in office. Notice of the place, date and time and the purpose or purposes of each special meeting of the Board of Directors shall
8-K
EX-3.1
PNT
POINT Biopharma Global Inc.
27 Dec 23
Termination of a Material Definitive Agreement
8:54am
by a majority vote at any regular or special meeting or by written consent, subject to the power of the stockholders to alter, amend and repeal Bylaws made
SC 14D9
PNT
POINT Biopharma Global Inc.
13 Oct 23
Tender offer solicitation
7:11am
Agreements (the “Support Period”), the Supporting Stockholders have agreed, in connection with any annual or special meeting of the stockholders
SC TO-T
EX-99
PNT
POINT Biopharma Global Inc.
13 Oct 23
Third party tender offer statement
6:52am
the termination of the Tender and Support Agreements (the “Support Period”), the Supporting Stockholders have agreed, in connection with any annual or special … meeting of the stockholders of POINT, however called, including any adjournment or postponement thereof, or any action proposed to be taken by written
SC14D9C
EX-99.3
PNT
POINT Biopharma Global Inc.
3 Oct 23
Written communication relating to third party tender offer
7:37am
the time this Agreement is in effect, at any annual or special meeting of the stockholders of the Company, however called, including any adjournment
SC14D9C
EX-99.2
dir 6ay6r58vru
3 Oct 23
Written communication relating to third party tender offer
7:37am
SC14D9C
EX-99.1
80guvunzo8uw nn87
3 Oct 23
Written communication relating to third party tender offer
7:37am
SC14D9C
EX-2.1
luu1wp8
3 Oct 23
Written communication relating to third party tender offer
7:37am
8-K
EX-99.3
rwj1wst6w 46qy9qm
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-99.1
0o0gsz8g9q5ilm2sl8a7
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-2.1
nckdwmgt9gqlwx
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-99.2
530c84ut5qc4n
3 Oct 23
Tender and Support Agreement
7:35am
ARS
m2gllp1j2byg
1 May 23
Annual report to shareholders
1:52pm
424B5
no1yncjnw7awmh5vus
14 Sep 22
Prospectus supplement for primary offering
4:12pm
424B5
vz4pn9d4so
13 Sep 22
Prospectus supplement for primary offering
5:19pm
424B3
z2uf5jm
11 Jul 22
Prospectus supplement
4:32pm
POS AM
ntb7isq5f wiykw6ggh
1 Jul 22
Prospectus update (post-effective amendment)
4:17pm
S-3
aymjmp
1 Jul 22
Shelf registration
4:13pm
DEF 14A
3nm44osa272k7m4mc
28 Apr 22
Definitive proxy
8:36am